Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
Henrich KO, Fischer M, Mertens D, Benner A, Wiedemeyer R, Brors B, Oberthuer A, Berthold F, Wei JS, Khan J, Schwab M, Westermann F.
Henrich KO, et al. Among authors: khan j.
Clin Cancer Res. 2006 Jan 1;12(1):131-8. doi: 10.1158/1078-0432.CCR-05-1431.
Clin Cancer Res. 2006.
PMID: 16397034